Skip to main content

Table 2 Dose and schedule of anti-TB drugs of investigational arm

From: Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial

Drug Dose Usage
Linezolid 600 mg/day for initial 2 months, then 300 mg/day Once
Delamanid 200 mg/day Divide in two, together with meal
Levofloxacin 750 mg (<  50 kg)
1000 mg (50–70 kg)
Once, before or after meal
Pyrazinamide 1000 mg (<  50 kg)
1500 mg (50–70 kg)
2000 mg (> 70 kg)